Page 2 - Generic Drugs

Making markets work for affordable medicines

Regulatory safeguards to ensure quality and efficacy of drugs are a necessary pre-condition for effective competition between generic and branded drugs

Pharmacy consolidation may disrupt domestic drug market: Credit Suisse

The report says if chemists are allowed to replace doctor's prescription with a generic drug, firms with high exposure to chronic therapeutic drugs will be impacted more

India seeks new preferential treatment from US on drugs, other goods

India accounts for 40 per cent of US generic drug imports, including the anti-malarial hydroxychloroquine, touted by US President Donald Trump in the fight against Covid-19.

Zydus Cadila gets USFDA nod to market generic drug to treat headache

The drug will be manufactured at Nesher Pharma's manufacturing facility at St. Louis in the US, the drug firm says

US charges generic drug firm Glenmark with conspiracy in price-fixing

Company says it strongly disagreed with the charge, has 'overwhelming evidence' to support its innocence.

First copies of Gilead coronavirus drug to start selling in Bangladesh

The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals

Branded generics: Uncertainty or opportunity?

The rules of the game in India's branded generics market are fuzzy to say the least

Organised generic drugs chain Medkart Pharmacy plans national foray

By adding over 250 stores in next three years, Medkart is looking to grow its turnover from Rs 20 crore currently to Rs 300 crore in the next three years

Price-fixing charges: Sun Pharma in talks with US to end anti-trust probe

Prosecutors have been investigating allegations that generic drugmakers conspired to prop up the prices of certain widely used medications for more than five years

Pharma industry needs to develop entire value chain: Dr Reddy's G V Prasad

According to Prasad, the relevance of Indian pharma sector as a provider of affordable alternative to the world remains intact

Sun Pharma announces tie-up for China foray; to develop 8 generic products

The total addressable market size for all these eight products is about $1 billion (according to recent IQVIA data) in mainland China

'Affordable' drive: Govt asks chemists to display generic drugs prominently

Experts believe the move will have little impact given limited production of generic drugs and authority of doctors in prescribing medicines.

Why public health facilities are failing to meet demand for generic drugs

Over 35% of the generic and branded drugs were purchased from private facilities across all survey sites

Lupin, Dr Reddy's, Glenmark and Taro see up to 40% decline in the US sales

Except a few, large pharmaceutical players see up to 40% decline in the US sales

Approval for generics drug up but US business shrinks for home firms

The trend is likely to continue for the next few quarters before the benefit from new drug launches start to accrue

Generic drug approvals on the rise in US; 101 applications get nod in Oct

Since April, top Indian firms have secured approvals for 203 drugs: Edelweiss Securities report

Prescribe the right pill

Doctors must be encouraged to prescribe generic drugs and not specific brands

Take the generic drug, patients are told - unless insurers say no

Pharma firms are cutting deals with insurance comapnies to favour their brand over cheaper generics

Ensuring that generics replace branded drugs

Substituting branded drugs with generics will be a challenging journey

Prescribing generic drugs will reduce patient confusion & medication errors

Drug names are long, complex and there are usually multiple brands for the same product